David C Dvorak has stepped down as Zimmer Biomet’s president, chief executive officer and member of the Board of Directors after 10 years at the helm of the company. He will remain in an advisory capacity to the company to smooth the transition.
Daniel P Florin—currently senior president and chief financial officer—will take the reigns as interim chief executive officer until a permanent successor is decided.
The Zimmer Biomet Board is using a recruitment agency specialising executive recruitment to identify and evaluate candidates for the permanent role.
The company has grown from approximately 3,000 employees in 2001 to 18,000 today, and has joined the Fortune 500 list. Over the past two years, it has made several significant acquisitions, purchasing companies such as LDR and MedTech.
